Scientists attend national patient retreat and share scientific updates on investigational EMD-101 for severe congenital neutropenia treatment.

Metrion Biosciences announced it has received notification from the MHRA that the Company is now a member of the UK GLP Compliance Monitoring Programme.

MediGO Platform Aims to Improve Access to Donated Organs and Shorten Transplant Wait Times. Acquisition Expands CareDx Digital Health Portfolio and Establishes Footprint in OPO Market

New automated kit overcomes major bottleneck in peptide production, providing optimized simultaneous workflows.

ARMGO Pharma, Inc. (ARMGO), announced the enrollment of the first patient in a Phase 2 proof of concept clinical trial using its Rycal ARM210 (also known as S48168), for the treatment of Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT).

Arrayjet, announced that it has partnered with Chemspace, the largest online catalogue of small molecules and biologics, to augment and streamline the Company’s small molecule microarray (SMM) service offering.

A landmark study demonstrates that precision oncology medicines could deliver a superior return on Investment for Pharma R&D vs their one size fits all counterparts.

Clinisys has announced it has launched Clinisys Laboratory Solutions™, with four enhanced solutions spanning the Clinisys Environmental Laboratory™, Clinisys Water Quality Laboratory™, Clinisys Toxicology Laboratory™ and Clinisys Public Health Laboratory™.

Sphere Fluidics has announced updates to its flagship platform, Cyto-Mine®, enabling it to be compliant with current Good Manufacturing Practice regulations enforced by the US FDA.

AMSBIO has published a blog about Dr. Satoshi Okamoto’s groundbreaking research on the production of induced pluripotent stem cells (iPSC)-derived liver organoids, and their significant potential in clinical research trials.